Österreichische Forschungsförderungsgesellschaft (FFG)
CATT Innovation Management GmbH (CATT)
Wirtschaftskammer Salzburg (WKS)
Steirische Wirtschaftförderungsgesellschaft (SFG)
Wirtschaftskammer Kärnten (WKK)
Standortagentur Tirol
WISTO - Wirtschafts-Standort Vorarlberg GmbH
AWS - austria wirtschaftsservice | erp-fonds
GUEST

Bioresponsive Nanoparticle Aggregates with medical, environmental and security applications

Profil TitelBioresponsive Nanoparticle Aggregates with medical, environmental and security applications

Referenz

10 GB 44O7 3GDS
HerkunftslandUnited Kingdom
KooperationsartAngebot
Eintrag/Änderung2010-02-17 / 2011-01-18
StatusDieses Profil ist abgelaufen! Falls Sie denoch Interesse haben, kontaktieren Sie uns. (2012-01-17) 

Kurzfassung

A UK university has developed a novel method for the reversible assembly/disassembly of nanoparticle aggregates which is triggered by enzyme reactions. The system has a wide range of applications from medical diagnostics and drug delivery to detection of bio-warfare agents. The university is looking for partners for licensing or joint further development according to specific needs.



Details

Bioresponsive materials offer a promising commercial opportunity and demonstrate great potential in the medical diagnostics and drug delivery sector. Compared with conventional chemistry, they are more sensitive, simple to use and more compatible with biological samples. Enzymes in patient samples such as blood and urine can be diagnostic of a number of disease conditions including HIV, Hepatitis C, various cancers, as well as Candida and MRSA infections. Hence bioresponsive materials, such as nanoparticle aggregates that can be triggered to switch between assembled/disassembled structures by enzymes, are valuable in developing specific diagnostic tests.

The invention is a novel method for the reversible assembly/disassembly of nanoparticle aggregates which is triggered by enzyme reactions. The nanomaterial consists of a chain of amino acids which can be selected to create specificity for different enzymes. This offers the potential to use the system for a wide range of applications. The enzyme cleaves the amino acid chain and causes disassembly of the nanoparticle aggregates. This is observable through a visible colour change which can also be quantified using a spectrometer.

Innovative Aspects:
• Real-time monitoring of enzyme activity
• High enzyme specificity achievable
• Read-out is rapid – within 5 minutes
• Single population of nanoparticles required
• 1 million times more sensitive than existing diagnostic tests (down to zeptogram/ml detection of enzymes)
• Simple, does not require complex post-processing or sophisticated equipment



Technologiesektor

- Diagnostik und Diagnosetechnologie, Radiologie
- Pharmazeutische Produkte / Medikamente
- Messung- und Monitoring von Umweltbelastungen

Anwendungsbereich

- Diagnostic
- Drug delivery and other equipment

Entwicklungstand

Development phase - Laboratory tested  

Patentrechte (IPR)

Patent(s) applied for but not yet granted  
 Have filed a patent on the technology.  

Kooperationstyp

- License Agreement
- Joint further development
- Testing of new applications
- Adaptation to specific needs

Type of partner sought: Industry or Academia
Specific area of activity of the partner:
Any of the areas above, from medical diagnostics and drug discovery, to environmental and defence/security applications.
Task to be performed by the partner sought: licensing / developing the technology further for specific applications.


Organisationstyp

Technical Centre/Technology transfer Centre     Größe: 11-50  


Möchten Sie mit dieser Firma
in Kontakt treten?

 
Ja




  • Dieses Technologieprofil entspricht nicht Ihren Bedürfnissen?
    Sie suchen eine maßgeschneiderte Lösung?

    => Erstellen Sie ein eigenes Suchprofil
    => In kürzester Zeit finden wir einen geeigneten Lösungsanbieter

  • Sie würden gerne ein eigenes Kooperationprofil verbreiten?
    Weitere Details